Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy
Smita Kumari, Rohan Gupta, Rashmi K. Ambasta, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188913-188913
Closed Access | Times Cited: 21

Showing 21 citing articles:

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 7
Glioblastoma Management in the Post-COVID-19 Era: Challenges, Strategies, and Adaptations
Xiaohui Ren, Ling Qin
IntechOpen eBooks (2025)
Closed Access
Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
Guochen Li, Haiyan Yang, Tengfei Ke, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B
Naijun Dong, Wenxin Qi, Lingling Wu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4
Xiangrui Meng, Zixuan Wang, Qingqing Yang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 2
Engineered mRNA Delivery Systems for Biomedical Applications
Ji Wang, Haofang Zhu, Jingjing Gan, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 7
Deciphering the causal relationship between plasma and cerebrospinal fluid metabolites and glioblastoma multiforme: a Mendelian Randomization study
Zhiwei Zhou, Haibin Leng
Aging (2024)
Open Access | Times Cited: 1
Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade
Lingtong Liu, Fei Li, Lingxue Zhang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 487, pp. 116969-116969
Closed Access | Times Cited: 1
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma
Mirko Rivara, Gabriella Nicolini, Alessio Malacrida, et al.
Results in Chemistry (2024) Vol. 9, pp. 101645-101645
Open Access | Times Cited: 1
Open‐Source Throttling of CD8+ T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy
Lei Dong, Yini Zhu, Haoge Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 44
Closed Access | Times Cited: 1
HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies
Yunhe Xie, Jiarong Ye, Hongliang Luo
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 849-865
Open Access | Times Cited: 2
Rehabilitation Exercises Supported by Monitor-Augmented Reality for Patients with High-Grade Glioma Undergoing Radiotherapy: Results of a Randomized Clinical Trial
Anna Pieczyńska, Ewa Zasadzka, Agnieszka Pilarska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6838-6838
Open Access | Times Cited: 2
LncBIRC3-OT promotes the malignant progression of glioma by interacting with RELA to upregulate stanniocalcin-1 expression
Renjie Wang, Qi Li, Xiaolei Chu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21777-e21777
Open Access | Times Cited: 2
Prognostic values and immune infiltration of KLF15, AQP7, AGPAT9 in glioma and glioblastoma
Ayobami Matthew Olajuyin, Onyinyechi Sharon Nwachukwu, Adefunke Kafayat Olajuyin, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access
Germline Co-deletion ofCDKN2AandCDKN2BGenes in Pleomorphic Xanthoastrocytoma: Case Report
Κωνσταντίνος Αγιαννιτόπουλος, ANASTASIA KATSELI, Kevisa Potska, et al.
In Vivo (2024) Vol. 38, Iss. 4, pp. 1671-1676
Open Access
Focused ultrasound-mediated enhancement of blood–brain barrier permeability for brain tumor treatment: a systematic review of clinical trials
Honglin Zhu, Caitlin Allwin, Monica G. Bassous, et al.
Journal of Neuro-Oncology (2024) Vol. 170, Iss. 2, pp. 235-252
Open Access
A Comprehensive review on exploring Thymoquinone as novel therapeutic molecule for clinical management of Glioblastoma Multiforme
Sagar Trivedi, Ujban Hussain, Rishabh Agade, et al.
Pharmacological Research - Natural Products (2024), pp. 100107-100107
Closed Access
Traitements du glioblastome – Trente années de progrès et rôle de l’immunothérapie
Jerzy Trojan
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 9, pp. 1317-1323
Closed Access
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
Guochen Li, Haiyan Yang, Tengfei Ke, et al.
Research Square (Research Square) (2024)
Open Access
The Role of PDCD6 in Stemness Maintenance of Glioblastoma
Xiyu Liu, Zi-Jian Shi, Xuantong Liu, et al.
Pathology - Research and Practice (2024) Vol. 264, pp. 155727-155727
Closed Access
Polo-like kinase 4 accelerates glioma malignant progression and vasculogenic mimicry by phosphorylating EphA2
Bo Wang, Run-ze Yu, Xiaoyang Zhang, et al.
Cancer Letters (2024), pp. 217397-217397
Closed Access
Page 1

Scroll to top